On this page
HUL seeks Delhi HC injunction over Beco ads targeting Vim and Surf Excel
Our read
Delhi HC pressure pushes Beco to qualify or modify anti-Vim and Surf Excel claims, accelerating a wider FMCG shift toward litigation-ready comparative advertising.
For operators
FMCG operators should tighten scientific substantiation, comparative-ad review and rapid-response protocols as challenger brands increasingly use safety and sustainability claims to attack category leaders.
Watch
Whether the court treats the claims as substantiated comparative advertising or as product disparagement.
The report,
HUL has sought a Delhi High Court injunction against sustainable D2C brand Beco’s campaign alleging Vim and Surf Excel ingredients can cause skin irritation. Beco says claims were independently tested and substantiated; advertisements remain unrestricted pending hearing.
Newer report , , CNBC-TV18 : HUL takes Horlicks into India’s ₹7,000-crore protein market
One email each morning: the day’s top moves in Indian retail, why each matters and what to watch. Free. Stop any time.
Reported figures
From the report. Source details below
- August 14
- 2018
- $13.4 Mn
Why it matters for the brand
For acquirers, the dispute reinforces the need to diligence a target’s claims-testing, advertising approvals and contingent legal liabilities before assigning strategic value to its sustainability positioning.
What to track next
- ASCI complaints or broader regulator attention toward safety and environmental claims in home-care advertising.
Likely next moves
Our read of what comes next — analysis, not reported by the source.
- Beco will likely submit test protocols, expert reports, claim substantiation, and evidence distinguishing its allegations from blanket product-safety accusations.
- Large FMCG advertisers may audit comparative-advertising copy, especially claims involving irritation, toxins, allergens, biodegradability, and environmental safety.
- D2C brands may shift from naming incumbents directly to ingredient-led education, side-by-side test disclosures, and qualified claims such as 'may be unsuitable for some skin types.'
The counter-case
The case against this reading — not reported by the source.
This may be a narrow ad-disparagement dispute rather than evidence of a broader shift in FMCG legal risk. HUL seeking an injunction does not establish that Beco's claims are false, nor does it prove that comparative advertising is becoming materially more dangerous for challenger brands. If Beco's substantiation is robust and its messaging is framed as ingredient-specific rather than alleging product harm, the case could ultimately reinforce the viability of evidence-backed comparison campaigns.
The source
First seen